title: An increased number of very-low-density lipoprotein particles is strongly associated with coronary heart disease in Japanese men, independently of intermediate-density lipoprotein or low-density lipoprotein.
abstract: BACKGROUND
  Japanese patients with coronary heart disease (CHD) usually have slightly elevated triglyceride levels but virtually normal low-density lipoprotein (LDL)-cholesterol levels.
  
  
  METHODS
  Case-control study.
  
  
  METHODS
  To explore the atherogenecity of mild hypertriglyceridemia, we measured very-low-density lipoprotein (VLDL) composition and apolipoprotein (apo) B in VLDL, intermediate-density lipoprotein (IDL), light LDL and dense LDL fractions separated by ultracentrifugation in 61 men with angiographically proven CHD and in 69 men without CHD. Apo B, E, C1 and C3 in VLDL were measured by enzyme-linked immunosorbent assay.
  
  
  RESULTS
  Although total- and LDL-cholesterol levels were similar in CHD and control participants, triglyceride levels were significantly higher and high-density lipoprotein (HDL)-cholesterol levels were lower in CHD patients. Triglyceride, cholesterol and apo C1 and E levels in VLDL were two-fold higher and VLDL-apo B level was three-fold higher in CHD than control patients. IDL-triglyceride levels were significantly elevated in CHD, but IDL-cholesterol level was not. Apo B levels of the dense LDL fraction were significantly elevated in CHD groups, but those of the light LDL fraction were not. These differences were constant when triglyceride levels matched between both groups. Multiple logistic regression analysis revealed that the VLDL-apo B and VLDL-apo C1 levels were significantly associated with the incidence of CHD independent of the plasma triglyceride, HDL-cholesterol or apo B levels in dense LDL.
  
  
  CONCLUSIONS
  These results suggest that an increased number of VLDL particles is strongly associated with CHD, independently of traditional risk factors or newly recognized atherogenic lipoproteins, such as IDL or small, dense LDL, in Japanese men.
authors.affiliation: Third Department of Internal Medicine, Showa University School of Medicine, Tokyo, Japan.
authors.forename: Shinji
authors.initials: S
authors.lastname: Koba
authors.forename: Tsutomu
authors.initials: T
authors.lastname: Hirano
authors.forename: Taro
authors.initials: T
authors.lastname: Sakaue
authors.forename: Hiroko
authors.initials: H
authors.lastname: Takeuchi
authors.forename: Mitsuru
authors.initials: M
authors.lastname: Adachi
authors.forename: Takashi
authors.initials: T
authors.lastname: Katagiri
mesh_terms: D001055:Apolipoproteins B / Q000097:blood; D044466:Asian People; D016022:Case-Control Studies; D002784:Cholesterol / Q000097:blood*; D003327:Coronary Disease / Q000097:blood* / Q000208:ethnology*; D006801:Humans; D015228:Hypertriglyceridemia / Q000097:blood; D007564:Japan; D008074:Lipoproteins / Q000097:blood*; D008077:Lipoproteins, LDL / Q000097:blood*; D008079:Lipoproteins, VLDL / Q000097:blood*; D016015:Logistic Models; D008297:Male; D008875:Middle Aged; D016036:Seroepidemiologic Studies
chemical_list: D001055:Apolipoproteins B; D008074:Lipoproteins; D008077:Lipoproteins, LDL; D008079:Lipoproteins, VLDL; C030104:lipoprotein cholesterol; D002784:Cholesterol